Last Update

2016-09-06T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Robert Fildes?

Dr. Robert A. Fildes

HQ Phone: (858) 207-4264

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

La Jolla Pharmaceutical Company

10182 Telesis Court 6Th Floor

San Diego, California 92121

United States

Company Description

La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The Company ... more

Find other employees at this company (82)

Background Information

Employment History

Senior Executive

Bristol-Myers Squibb Company

President, and and Or Chief Executive Officer

Atlantic Technology Ventures , Inc.

Senior Executive

GlaxoSmithKline plc

Affiliations

Director
Inimex Pharmaceuticals Inc.

President
SB2

Executive Advisor
CM Capital Investments

Board Member
CIBA Vision Corporation

Member of the Investment Committee
Royal Canadian Bank

Board Member
HiQSoft Inc.

President, and and Or Chief Executive Officer
Biogen Idec Inc.

Board Member
Viagene , Inc.

Board Member
Carrington Laboratories , Inc.

Founder and Board Member
Industrial Biotechnology Association

Member of the School of Business Advisory Board
Haas School of Business

Board Member
Association of Biotechnology Led Enterprises

Education

B.Sc.

chemistry and human physiology

University of London

D.C.C. degree

Microbial Biochemistry

University of London

DCC degree

Microbial Biochemistry

University of London

PhD

Biochemical Genetics

University of London

Web References (97 Total References)


celacare-people

www.celacare.com [cached]

Dr. Robert Fildes, a biotechnology industry veteran who previously served as president, and/or CEO of Cetus Corporation, Scotgen Biopharmaceuticals, Atlantic Pharmaceuticals and Biogen Inc., and as a senior executive at Bristol Myers Squibb and GlaxoSmithKline, will also serve as an advisor to the company. Currently he serves as president of SB2, Inc. and as a director of Inimex Pharmaceuticals, Inc. and La Jolla Pharmaceutical Company. Dr. Fildes holds a D.C.C. degree in Microbial Biochemistry and a Ph.D. in Biochemical Genetics from the University of London.


La Jolla Pharmaceutical Company :: Press Release

www.ljpc.com [cached]

Also in connection with the acquisition, the former members of the management team, Deirdre Y. Gillespie, M.D., President and Chief Executive Officer, and Gail A. Sloan, CPA, Chief Financial Officer, and the former members of the Board of Directors, Robert A. Fildes, Ph.D., Chairman, Bertrand C. Liang, M.D., Ph.D., and Deirdre Y. Gillespie, M.D., have resigned.


Also in connection with the acquisition, ...

ljpc.com [cached]

Also in connection with the acquisition, the former members of the management team, Deirdre Y. Gillespie, M.D., President and Chief Executive Officer, and Gail A. Sloan, CPA, Chief Financial Officer, and the former members of the Board of Directors, Robert A. Fildes, Ph.D., Chairman, Bertrand C. Liang, M.D., Ph.D., and Deirdre Y. Gillespie, M.D., have resigned.


January | 2012 | La Jolla Pharmaceutical

ljpc.com [cached]

Also in connection with the acquisition, the former members of the management team, Deirdre Y. Gillespie, M.D., President and Chief Executive Officer, and Gail A. Sloan, CPA, Chief Financial Officer, and the former members of the Board of Directors, Robert A. Fildes, Ph.D., Chairman, Bertrand C. Liang, M.D., Ph.D., and Deirdre Y. Gillespie, M.D., have resigned.


Investor Relations - Directors & Management Team

www.ljpc.com [cached]

Robert A. Fildes, Ph.D.

...
Robert A. Fildes, Ph.D. President, SB2, Inc.
Robert A. Fildes, Ph.D. has been a director since 1991. Since January 1998, Dr. Fildes has served as President of SB2, Inc., a privately held company that licenses antibody technology. From June to December 1998, Dr. Fildes served as Chief Executive Officer of Atlantic Pharmaceuticals, a publicly held company in the field of biotechnology. From 1993 to 1997, Dr. Fildes was the Chairman and Chief Executive Officer of Scotgen Biopharmaceuticals, Inc., a privately held company in the field of human monoclonal antibody technology. From 1990 to 1993, Dr. Fildes was an independent consultant in the biopharmaceutical industry. He was the president and Chief Executive Officer of Cetus Corporation, a publicly held biotechnology company, from 1982 to 1990. From 1980 to 1982, Dr. Fildes was the President of Biogen, Inc., which merged with IDEC Pharmaceuticals Corporation in 2003 to form Biogen Idec, a publicly held biopharmaceutical company, and from 1975 to 1980, he was the Vice President of Operations for the Industrial Division of Bristol-Myers Squibb Company. From April 2002 to April 2003, Dr. Fildes was a director of Polymerat Pty. Ltd. (now Bio-Layer Pty. Ltd.), a privately held company that develops surfaces for carrying out biological reactions. Dr. Fildes is currently a director of Inimex Pharmaceuticals, Inc., a privately held Canadian biotechnology company. Dr. Fildes holds a D.C.C. degree in Microbial Biochemistry and a Ph.D. in Biochemical Genetics from the University of London.

Similar Profiles

Other People with this Name

Other people with the name Fildes

Stephen Fildes
Cricket Gold Coast Limited

John Fildes
The Institute of Tribology and Coatings

Luke Fildes
Fildes

David Fildes
University of Wollongong

Ricky Fildes
TribePost Ltd

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory